-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IClG5vQHK/4vwoory7LCMv2oSZAlzZDTUNUh0XsrvMlB+dbMCoGkJnS+vjFxz0+f plmawv3mB3rWpzGqeArD8A== 0001412292-10-000005.txt : 20100702 0001412292-10-000005.hdr.sgml : 20100702 20100702142032 ACCESSION NUMBER: 0001412292-10-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100630 FILED AS OF DATE: 20100702 DATE AS OF CHANGE: 20100702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Darazsdi Daniel G CENTRAL INDEX KEY: 0001412292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 10935446 MAIL ADDRESS: STREET 1: C/O PHARMACEUTICAL PRODUCT DEVELOPMENT STREET 2: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-06-30 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001412292 Darazsdi Daniel G 929 NORTH FRONT STREET WILMINGTON NC 28401 0 1 0 0 Chief Financial Officer Common Stock 2010-06-30 5 I 0 463 19.92 A 11963 D Stock Options (to buy) 26.64 2011-06-17 2020-06-17 Common Stock 30000 30000 D Stock Options (to buy) 20.45 2011-02-25 2020-02-25 Common Stock 62104 62104 D Stock Options (to buy) 25.74 2010-02-18 2019-02-18 Common Stock 62104 62104 D Stock Options (to buy) 19.94 2009-11-20 2018-11-20 Common Stock 23289 23289 D Stock Options (to buy) 37.69 2009-10-03 2018-10-03 Common Stock 23289 23289 D Stock Options (to buy) 43.26 2009-02-20 2018-02-20 Common Stock 46578 46578 D Stock Options (to buy) 34.15 2008-10-01 2017-10-01 Common Stock 93156 93156 D 10,000 shares of restricted stock were granted upon the Reporting Person's acceptance of employment. These shares vest in three equal increments on 10/1/08, 10/1/09 and 10/1/10. Also included are shares acquired under the automatic dividend reinvestment provision of the Company's Employee Stock Purchase Plan. These options vest in three equal increments on 6/17/11, 6/17/12 and 6/17/13. These options vest in three equal increments on 2/25/11, 2/25/12 and 2/25/13. These options vest in three equal increments on 2/18/10, 2/18/11 and 2/18/12. These optons vest in three equal increments on 11/20/09, 11/20/10 and 11/20/11. These options vest in three equal increments on 10/3/09, 10/03/10 and 10/3/11. These options vest in three equal increments on 2/20/09, 2/20/10 and 2/20/11. These options vest in three equal increments on 10/1/08, 10/1/09 and10/1/10. Lisa C. Noecker attorney-in-fact for Daniel G. Darazsdi 2010-07-02 -----END PRIVACY-ENHANCED MESSAGE-----